These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 35946480)
1. Pseudohypoaldosteronism associated with hypertrophic cardiomyopathy, hypertension and thrombocytosis due to mutation in the ELAC2 gene: a case report. Mendes LC; de Oliveira Magalhães R; Pereira Dos Santos RK; Araújo RS J Pediatr Endocrinol Metab; 2022 Nov; 35(11):1437-1442. PubMed ID: 35946480 [TBL] [Abstract][Full Text] [Related]
2. [Mineralocorticoid resistance: pseudohypoaldosteronism type 1]. Fernandes-Rosa FL; Antonini SR Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):373-81. PubMed ID: 17546235 [TBL] [Abstract][Full Text] [Related]
3. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations. Zennaro MC; Fernandes-Rosa F J Endocrinol; 2017 Jul; 234(1):T93-T106. PubMed ID: 28348114 [TBL] [Abstract][Full Text] [Related]
4. Pseudohypoaldosteronism type 1 due to a novel mutation in the mineralocorticoid receptor gene. Loomba-Albrecht LA; Nagel M; Bremer AA Horm Res Paediatr; 2010; 73(6):482-6. PubMed ID: 20453518 [TBL] [Abstract][Full Text] [Related]
5. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1. Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129 [TBL] [Abstract][Full Text] [Related]
6. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism. Sartorato P; Khaldi Y; Lapeyraque AL; Armanini D; Kuhnle U; Salomon R; Caprio M; Viengchareun S; Lombès M; Zennaro MC Mol Cell Endocrinol; 2004 Mar; 217(1-2):119-25. PubMed ID: 15134810 [TBL] [Abstract][Full Text] [Related]
7. Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town. Serra G; Antona V; D'Alessandro MM; Maggio MC; Verde V; Corsello G Ital J Pediatr; 2021 Jun; 47(1):138. PubMed ID: 34134742 [TBL] [Abstract][Full Text] [Related]
8. A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene. Lee SE; Jung YH; Han KH; Lee HK; Kang HG; Ha IS; Choi Y; Cheong HI Korean J Pediatr; 2011 Feb; 54(2):90-3. PubMed ID: 21503203 [TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism. Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228 [TBL] [Abstract][Full Text] [Related]
10. Phenotypic diversity and correlation with the genotypes of pseudohypoaldosteronism type 1. Gopal-Kothandapani JS; Doshi AB; Smith K; Christian M; Mushtaq T; Banerjee I; Padidela R; Ramakrishnan R; Owen C; Cheetham T; Dimitri P J Pediatr Endocrinol Metab; 2019 Sep; 32(9):959-967. PubMed ID: 31301676 [TBL] [Abstract][Full Text] [Related]
12. Miliaria rubra and thrombocytosis in pseudohypoaldosteronism: case report. Onal H; Adal E; Ersen A; Onal Z; Keskindemirci G Platelets; 2012; 23(8):645-7. PubMed ID: 22150373 [TBL] [Abstract][Full Text] [Related]
13. A novel nonsense mutation of the mineralocorticoid receptor gene in the renal form of pseudohypoaldosteronism type 1. Uchida N; Shiohara M; Miyagawa S; Yokota I; Mori T J Pediatr Endocrinol Metab; 2009 Jan; 22(1):91-5. PubMed ID: 19344080 [TBL] [Abstract][Full Text] [Related]
14. A novel frameshift mutation in NR3C2 leads to decreased expression of mineralocorticoid receptor: a family with renal pseudohypoaldosteronism type 1. Kawashima Sonoyama Y; Tajima T; Fujimoto M; Hasegawa A; Miyahara N; Nishimura R; Hashida Y; Hayashi A; Hanaki K; Kanzaki S Endocr J; 2017 Jan; 64(1):83-90. PubMed ID: 27725360 [TBL] [Abstract][Full Text] [Related]
15. Renin-aldosterone system evaluation over four decades in an extended family with autosomal dominant pseudohypoaldosteronism due to a deletion in the NR3C2 gene. Hanukoglu A; Vargas-Poussou R; Landau Z; Yosovich K; Hureaux M; Zennaro MC J Steroid Biochem Mol Biol; 2020 Nov; 204():105755. PubMed ID: 33017655 [TBL] [Abstract][Full Text] [Related]
16. Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene. Fernandes-Rosa FL; de Castro M; Latronico AC; Sippell WG; Riepe FG; Antonini SR J Clin Endocrinol Metab; 2006 Sep; 91(9):3671-5. PubMed ID: 16757525 [TBL] [Abstract][Full Text] [Related]
17. Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity. Riepe FG; Krone N; Morlot M; Ludwig M; Sippell WG; Partsch CJ J Clin Endocrinol Metab; 2003 Apr; 88(4):1683-6. PubMed ID: 12679457 [TBL] [Abstract][Full Text] [Related]